|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01558 HEC CJ PHARM
Nominal 
9.570 +0.060 (+0.631%) Profitability Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| ROAA (%) | 16.178% | 0.683% | -5.846% | 8.621% | 26.514% |
| ROAE (%) | 28.836% | 1.310% | -10.985% | 18.053% | 48.931% |
| Return on Capital Employed (%) | 23.688% | 1.102% | -6.316% | 15.545% | 25.244% |
Margin Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Gross Profit Margin (%) | 79.207% | 75.998% | 52.933% | 85.029% | 85.189% |
| EBITDA Margin (%) | 42.699% | 18.470% | -19.141% | 57.594% | 40.548% |
| Pre-tax Profit Margin (%) | 33.787% | 1.053% | -73.013% | 43.032% | 36.456% |
| Net Profit Margin (%) | 31.656% | 2.046% | -64.309% | 35.750% | 30.827% |
Liquidity Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Current Ratio (X) | 1.397 X | 1.015 X | 1.662 X | 0.784 X | 2.306 X |
| Quick Ratio (X) | 1.303 X | 0.951 X | 1.436 X | 0.694 X | 2.223 X |
Leverage Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Total Liabilities / Total Assets(%) | 37.733% | 48.948% | 42.886% | 46.622% | 53.360% |
| Total Debt / Total Assets (%) | 20.474% | 32.144% | 30.294% | 31.488% | 30.621% |
| Net Debt / Total Assets (%) | 7.336% | 24.376% | 19.564% | 10.100% | 2.584% |
| Total Debt / Shareholders' Funds (%) | 32.882% | 64.943% | 54.982% | 61.554% | 68.849% |
| Long Term Debt / Shareholders' Funds (%) | 3.648% | 11.751% | 54.147% | 3.882% | 65.840% |
| Net Debt / Shareholders' Funds (%) | 11.781% | 49.250% | 35.508% | 19.744% | 5.810% |
| Net Cash / (Debt) ($) | (934.915M) | (2.898B) | (2.062B) | (965.690M) | (256.122M) |
| Net Cash / (Debt) per share ($) | (1.062) | (3.294) | (2.344) | (1.097) | (0.285) |
| Total Debt / Capital Employed (%) | 31.019% | 54.998% | 34.326% | 55.752% | 39.934% |
| Interest Coverage Ratio (X) | 10.353 X | 1.140 X | N/A | 5.138 X | 12.095 X |
Efficiency Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Inventory Turnover (Day) | 100.964 Day | 120.747 Day | 279.194 Day | 296.212 Day | 70.600 Day |
| Receivables Turnover (Day) | 89.253 Day | 72.360 Day | 187.645 Day | 206.499 Day | 92.837 Day |
| Payables Turnover (Day) | 10.654 Day | 13.777 Day | 70.875 Day | 32.973 Day | 7.692 Day |
| Remarks: | Real time quote last updated: 19/11/2024 13:53 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 684,731 |
| %Change | -33.489% |
| EPS / (LPS) | RMB 0.780 |
| NBV Per Share (¥) | RMB 9.847 |